Botanic Healthcare is thrilled to announce a significant funding milestone, having successfully raised $30 million in our latest round of investment. This funding will empower us to accelerate our innovative research and development initiatives, further solidifying our position as a leader in the nutra ingredients sector. With a commitment to revolutionizing health solutions through cutting-edge manufacturing of bio-available ingredients, we dedicate ourselves to addressing the ever-evolving challenges in healthcare and nutrition. Our expertise spans a wide array of products, including liposomes, natural vitamins and minerals, and carotenoids, all of which are produced in accordance with stringent global standards, including USFDA CGMP norms and various organic certifications. This new infusion of capital will enhance our eco-friendly technologies and enable us to expand our product offerings while maintaining the highest quality standards. As we continue to export to 36 countries worldwide, our committed teams ensure compliance and excellence across every market segment. The recent recognition as the Best Nutraceutical Ingredients Manufacturer of the Year 2024 by ASSOCHAM is a testament to our relentless efforts and innovative spirit. These funds will not only fuel our passion for pioneering research but will also enhance our ability to collaborate with partners to bring innovative and functional formulations to life. At Botanic Healthcare, we believe that through our unwavering dedication to quality and innovation, we can transform the landscape of health and nutrition for better global outcomes.




